Cargando…
Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer
Platinum-based agents are the main treatment option in ovarian cancer (OC). Herein, we report a poly(lactic-co-glycolic acid) (PLGA) nanoparticle (NP) encapsulating platinum (II), which is targeted to a cell-spanning protein overexpressed in above 90% of late-stage OC, mucin 1 (MUC1). The NP is coat...
Autores principales: | Wlodarczyk, Marek T., Dragulska, Sylwia A., Chen, Ying, Poursharifi, Mina, Acosta Santiago, Maxier, Martignetti, John A., Mieszawska, Aneta J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961376/ https://www.ncbi.nlm.nih.gov/pubmed/36839929 http://dx.doi.org/10.3390/pharmaceutics15020607 |
Ejemplares similares
-
Enzymatic synthesis of tryptamine and its halogen derivatives selectively labeled with hydrogen isotopes
por: Dragulska, Sylwia, et al.
Publicado: (2013) -
Optically Coupled PtOEP and DPA Molecules Encapsulated into PLGA-Nanoparticles for Cancer Bioimaging
por: Vepris, Olena, et al.
Publicado: (2022) -
In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
por: Fernandes, Renata S., et al.
Publicado: (2022) -
pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium
por: Khanal, Shalil, et al.
Publicado: (2016) -
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
por: Chang, Chi-Son, et al.
Publicado: (2023)